United Therapeutics Corporation Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- United Therapeutics Corporation share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2016-06-30 was 73.44K shares, a 78.76% decline year-over-year.
- United Therapeutics Corporation share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2016-03-31 was 81.11K shares, a 67.79% decline year-over-year.
- United Therapeutics Corporation share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2015-12-31 was 177.83K shares, a 37.51% decline year-over-year.
- United Therapeutics Corporation share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2015-09-30 was 210.26K shares, a 54.35% decline year-over-year.
- United Therapeutics Corporation share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 747.49K shares, a 84.32% increase from fiscal 2021.
- United Therapeutics Corporation share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2021 was 405.54K shares, a 13.11% decline from fiscal 2020.
- United Therapeutics Corporation share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2020 was 466.73K shares, a 143.71% increase from fiscal 2019.
- United Therapeutics Corporation share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2019 was 191.51K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2022-12-31 | 747.49K shares 10-K · filed 2023-02-22 | |
| 2021-12-31 | 405.54K shares 10-K · filed 2023-02-22 | |
| 2020-12-31 | 466.73K shares 10-K · filed 2023-02-22 | |
| 2019-12-31 | 191.51K shares 10-K · filed 2022-02-24 | |
| 2016-06-30 | 73.44K shares 10-Q · filed 2016-07-28 | 542.63K shares derived: sum of 4 quarters · filed 2016-07-28 |
| 2016-03-31 | 81.11K shares 10-Q · filed 2016-04-28 | 814.85K shares derived: sum of 4 quarters · filed 2016-07-28 |
| 2015-12-31 | 177.83K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | 985.58K shares 10-K · filed 2016-02-25 |
| 2015-09-30 | 210.26K shares 10-Q · filed 2015-10-27 | 1.09M shares derived: sum of 4 quarters · filed 2016-07-28 |
| 2015-06-30 | 345.66K shares 10-Q · filed 2016-07-28 | 1.34M shares derived: sum of 4 quarters · filed 2016-07-28 |
| 2015-03-31 | 251.84K shares 10-Q · filed 2016-04-28 | 1.44M shares derived: sum of 4 quarters · filed 2016-04-28 |
| 2014-12-31 | 284.57K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | 1.46M shares 10-K · filed 2016-02-25 |
| 2014-09-30 | 460.60K shares 10-Q · filed 2015-10-27 | 1.39M shares derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-06-30 | 445.95K shares 10-Q · filed 2015-07-28 | 1.24M shares derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-03-31 | 271.24K shares 10-Q · filed 2015-04-28 | 997.99K shares derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-12-31 | 210.75K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | 876.12K shares 10-K · filed 2016-02-25 |
| 2013-09-30 | 310.67K shares 10-Q · filed 2014-10-28 | 854.79K shares derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-06-30 | 205.32K shares 10-Q · filed 2014-07-29 | 790.52K shares derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-03-31 | 149.37K shares 10-Q · filed 2014-04-29 | 652.40K shares derived: sum of 4 quarters · filed 2015-02-24 |
| 2012-12-31 | 189.43K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | 575.94K shares 10-K · filed 2015-02-24 |
| 2012-09-30 | 246.40K shares 10-Q · filed 2013-10-29 | 403.63K shares derived: sum of 4 quarters · filed 2014-02-25 |
| 2012-06-30 | 67.20K shares 10-Q · filed 2013-07-25 | 177.37K shares derived: sum of 4 quarters · filed 2014-02-25 |
| 2012-03-31 | 72.92K shares 10-Q · filed 2013-04-25 | 433.93K shares derived: sum of 4 quarters · filed 2014-02-25 |
| 2011-12-31 | 17.12K shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | 837.69K shares 10-K · filed 2014-02-25 |
| 2011-09-30 | 20.14K shares 10-Q · filed 2012-11-01 | |
| 2011-06-30 | 323.76K shares 10-Q · filed 2012-07-26 | |
| 2011-03-31 | 476.68K shares 10-Q · filed 2012-04-26 | |
| 2010-12-31 | 3.34M shares 10-K · filed 2013-02-26 | |
| 2009-12-31 | 955.94K shares 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |